NCT03293238

Brief Summary

This study will compare the accuracy and patient reported outcomes between four different techniques used to perform a knee injection.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
63

participants targeted

Target at P50-P75 for not_applicable knee-osteoarthritis

Timeline
Completed

Started Nov 2011

Longer than P75 for not_applicable knee-osteoarthritis

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 3, 2011

Completed
5.9 years until next milestone

First Submitted

Initial submission to the registry

September 18, 2017

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 26, 2017

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2018

Completed
1.8 years until next milestone

Results Posted

Study results publicly available

November 6, 2019

Completed
Last Updated

August 8, 2022

Status Verified

August 1, 2022

Enrollment Period

6.3 years

First QC Date

September 18, 2017

Results QC Date

January 8, 2019

Last Update Submit

August 4, 2022

Conditions

Keywords

kneeosteoarthritisultrasoundsonographyinjection

Outcome Measures

Primary Outcomes (1)

  • Number of Participants With Successful Knee Injection

    To assess presence or absence of contrast medium within the target knee joint as determined by a blinded radiologist. If contrast medium could be observed in the joint then the injection was considered a success.

    Procedure visit 3 (3-4 weeks after 1st injection)

Secondary Outcomes (2)

  • Procedural Satisfaction Score at 3 Months Post Injection

    3 month follow-up appointment following 3rd injection

  • Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Score

    Pre-Injection and 3 month follow-up appointment following 3rd injection

Study Arms (4)

Joint Line Ultrasound

ACTIVE COMPARATOR

Patients assigned to this group receive a standard medial or lateral joint line injection of Euflexxa aided by ultrasound guidance while sitting up.

Procedure: Joint line ultrasound

Joint Line Landmark

SHAM COMPARATOR

Patients assigned to this group receive a standard medial or lateral joint line injection of Euflexxa without ultrasound guidance while sitting up.

Procedure: Joint line landmark

Suprapatellar Ultrasound Guided

ACTIVE COMPARATOR

Patients assigned to this group receive an injection of Euflexxa while lying down into the suprapatellar pouch aided by ultrasound guidance.

Procedure: Suprapatellar ultrasound guided

Suprapatellar Landmark

SHAM COMPARATOR

Patients assigned to this group receive an injection of Euflexxa while lying down into the suprapatellar pouch without ultrasound guidance.

Procedure: Suprapatellar Landmark

Interventions

Patients will be sitting with knee bent at 90 degrees. Clinician will palpate extremity to determine if a medial or lateral approach will be made for the injection of Euflexxa into the joint space. The procedure will be aided by real time visualization utilizing ultrasound guidance.

Also known as: JLUS
Joint Line Ultrasound

Patients will be sitting with knee bent at 90 degrees. Clinician will palpate extremity to determine if a medial or lateral approach will be made for the injection of Euflexxa into the joint space. The procedure will not be aided by ultrasound guidance, but completed based strictly on tactile feedback from the injecting physician.

Also known as: JLL
Joint Line Landmark

Patients will be lying supine on exam table. Ultrasound will be used to capture a longitudinal view of the proximal patella and the plane between the prefemoral fat pad and suprapatellar fat pad. After the desired visualization is achieved, injection of Euflexxa will be made within the suprapatellar pouch.

Also known as: SPUS
Suprapatellar Ultrasound Guided

Patients will be lying supine on exam table. Injecting physician will insert needle lateral to the vastus lateralis toward the suprapatellar pouch, and will inject of Euflexxa once it is believed that the needle tip is in the pouch.

Also known as: SPL
Suprapatellar Landmark

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female, age 18 to 90
  • Clinician determined need for intra-articular knee injection
  • Radiograph confirmed grade 1-4 Kellgren Lawrence osteoarthritis scale

You may not qualify if:

  • Allergy to contrast dye, shellfish
  • Allergy to egg product or hyaluronate
  • Allergy to lidocaine
  • Localized skin infection at planned site of injection
  • Inability to complete follow-up phone call three months following the injection
  • Viscosupplementation injection within 6 months of the current evaluation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Andrews Research & Education Foundation

Gulf Breeze, Florida, 32561, United States

Location

Related Publications (9)

  • Peat G, McCarney R, Croft P. Knee pain and osteoarthritis in older adults: a review of community burden and current use of primary health care. Ann Rheum Dis. 2001 Feb;60(2):91-7. doi: 10.1136/ard.60.2.91.

    PMID: 11156538BACKGROUND
  • Jackson DW, Evans NA, Thomas BM. Accuracy of needle placement into the intra-articular space of the knee. J Bone Joint Surg Am. 2002 Sep;84(9):1522-7. doi: 10.2106/00004623-200209000-00003.

    PMID: 12208907BACKGROUND
  • Wiler JL, Costantino TG, Filippone L, Satz W. Comparison of ultrasound-guided and standard landmark techniques for knee arthrocentesis. J Emerg Med. 2010 Jul;39(1):76-82. doi: 10.1016/j.jemermed.2008.05.012. Epub 2008 Dec 5.

    PMID: 19062223BACKGROUND
  • Esenyel C, Demirhan M, Esenyel M, Sonmez M, Kahraman S, Senel B, Ozdes T. Comparison of four different intra-articular injection sites in the knee: a cadaver study. Knee Surg Sports Traumatol Arthrosc. 2007 May;15(5):573-7. doi: 10.1007/s00167-006-0231-6. Epub 2006 Dec 6.

    PMID: 17149645BACKGROUND
  • Naredo E, Cabero F, Beneyto P, Cruz A, Mondejar B, Uson J, Palop MJ, Crespo M. A randomized comparative study of short term response to blind injection versus sonographic-guided injection of local corticosteroids in patients with painful shoulder. J Rheumatol. 2004 Feb;31(2):308-14.

    PMID: 14760802BACKGROUND
  • Berkoff DJ, Miller LE, Block JE. Clinical utility of ultrasound guidance for intra-articular knee injections: a review. Clin Interv Aging. 2012;7:89-95. doi: 10.2147/CIA.S29265. Epub 2012 Mar 20.

    PMID: 22500117BACKGROUND
  • Cunnington J, Marshall N, Hide G, Bracewell C, Isaacs J, Platt P, Kane D. A randomized, double-blind, controlled study of ultrasound-guided corticosteroid injection into the joint of patients with inflammatory arthritis. Arthritis Rheum. 2010 Jul;62(7):1862-9. doi: 10.1002/art.27448.

    PMID: 20222114BACKGROUND
  • Im SH, Lee SC, Park YB, Cho SR, Kim JC. Feasibility of sonography for intra-articular injections in the knee through a medial patellar portal. J Ultrasound Med. 2009 Nov;28(11):1465-70. doi: 10.7863/jum.2009.28.11.1465.

    PMID: 19854960BACKGROUND
  • Hong BY, Lim SH, Cho YR, Kim HW, Ko YJ, Han SH, Lee JI. Detection of knee effusion by ultrasonography. Am J Phys Med Rehabil. 2010 Sep;89(9):715-21. doi: 10.1097/PHM.0b013e3181e29c55.

    PMID: 20531157BACKGROUND

MeSH Terms

Conditions

Osteoarthritis, KneeOsteoarthritis

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Results Point of Contact

Title
Dr. Joshua Hackel
Organization
Andrews Research & Education Foundation

Study Officials

  • Joshua Hackel, MD

    Andrews Institute for Orthopaedic & Sports Medicine

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Patients will be blindfolded for the duration of their procedure. Investigator will always place ultrasound probe on patient's knee regardless of group assignment to eliminate bias. To further enhance blinding, the ultrasound screen will placed on freeze for the patients randomized into the groups without ultrasound guidance. Radiologist will be blinded to patient's group assignment.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Patients will be randomized into one of four intervention arms for the purpose of obtaining patient reported outcomes as it relates to the accuracy of injections into the knee joint with or without ultrasound guidance.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 18, 2017

First Posted

September 26, 2017

Study Start

November 3, 2011

Primary Completion

February 1, 2018

Study Completion

February 1, 2018

Last Updated

August 8, 2022

Results First Posted

November 6, 2019

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share

Locations